High-throughput methods for measuring heparanase activity and screening potential antimetastatic and anti-inflammatory agents

Analytical Biochemistry

Volumn 333, Issue 2, 2004, Pages 389-398

  Huang, Kuo Sen ^a   Holmgren, Janna ^a   Reik, Linda ^a   Lucas McGady, Debra ^a   Roberts, John ^a   Liu, Chao Min ^a   Levin, Wayne ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CHELATION; COENZYMES; DIAGNOSIS; FLUORESCENCE; FLUOROPHORES; PATHOLOGY; SULFUR COMPOUNDS;

ANTI-INFLAMMATORY AGENTS; EXTRACELLULAR MATRICES; FIBROBLAST GROWTH FACTOR; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENCE INTENSITY MEASUREMENT; HEPARANASE INHIBITORS; HIGH-THROUGHPUT METHOD; POTENTIAL INHIBITORS;

EUROPIUM COMPOUNDS;

ANTIINFLAMMATORY AGENT; ANTIMETASTATIC AGENT; BIOTIN; ENZYME INHIBITOR; EUROPIUM; FIBROBLAST GROWTH FACTOR; FLUORESCEIN ISOTHIOCYANATE; HEPARANASE; HEPARANASE INHIBITOR; HEPARIN; STREPTAVIDIN; UNCLASSIFIED DRUG;

ARTICLE; CHELATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; FLUORESCENCE ANALYSIS; HIGH THROUGHPUT SCREENING; MICROTITER PLATE ASSAY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ROBOTICS; TECHNIQUE;

EID: 4644236474     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2004.06.023     Document Type: Article

References (35)

1. R.L. Jackson, S.J. Busch, and A.L. Cardin Glysosaminoglycans: molecular properties, protein interactions and role in physiological processes Physiol. Rev. 71 1991 481 539
2. L. Kjellen, and U. Lindahl Proteoglycans: structures and interactions Annu. Rev. Biochem. 60 1991 443 475
3. T.N. Wight, M.G. Kinsella, and E.E. Qwarnstromn The role of proteoglycans in cell adhesion, migration, and proliferation Curr. Opin. Cell Biol. 4 1992 793 801
4. R. Ishai-Michaeli, A. Eldor, and I. Vlodavsky Heparanase activity expressed by platelets, neutrophils and lymphoma cells releases active fibroblast growth factor from extracellular matrix Cell Regul. 1 1990 833 842
5. J. Schlessinger, I. Lax, and M. Lemmon Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell 83 1995 357 360
6. S. Najjam, R.V. Gibbs, M.Y. Gordon, and C.C. Rider Characterization of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach Cytokine 9 1997 1013 1022
7. S. Eisenberg, E. Sehayek, T. Olivercrona, and I. Vlodavsky Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix J. Clin. Invest. 90 1992 2013 2021
8. J.G. Schulz, D. Megow, R. Reszka, A. Villringer, K.M. Einhaupl, and U. Dirnagl Evidence that glypican is a receptor mediating beta-amyloid neurotoxicity in PC12 cells Eur. J. Neurosci. 10 1998 2085 2093
9. R.F. Sewell, P.E. Brenchley, and N.P. Mallick Human mononuclear cells contain an endoglycosidase specific for heparan sulfate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate Biochem. J. 264 1989 777 783
10. M.A. Kosir, C.C. Quinn, K.L. Zukowski, D.J. Grignon, and S. Ledbetter Human prostate carcinoma cells produce extracellular heparanase J. Surg. Res. 67 1997 98 105
11. K. Godder, I. Vlodavsky, A. Eldor, B.B. Weksler, A. Haimovvitz-Friedman, and Z. Fuks Heparanase activity in cultured endothelial cells J. Cell Physiol. 148 1991 274 280
12. I. Vlodavsky, A. Eldor, A. Haimovitz-Friedman, Y. Metzner, R. Ishai-Michaeli, O. Lider, Y. Naparstek, I.R. Cohen, and Z. Fuks Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation Invas. Metast. 12 1992 112 127
13. I. Vlodavsky, Y. Friedmann, M. Elkin, H. Aingorn, R. Atzmon, R. Ishai-Michaeli, M. Bitan, O. Pappo, T. Peretz, I. Michal, L. Spector, and I. Pecker Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis Nat. Med. 5 1999 793 802
14. M. Ikuta, K.A. Podyma, K. Maruyama, S. Enomoto, and M. Yanagishita Expression of heparanase in oral cancer cell lines and oral cancer tissues Oral Oncol. 37 2001 177 184
15. J.B. Maxhimer, R.M. Quiros, R. Stewart, K. Dowlatshahi, P. Gattuso, M. Fan, R.A. Prinz, and X. Xu Heparanase-1 expression is associated with the metastatic potential of breast cancer Surgery 132 2002 326 333
16. M. Elkin, I. Cohen, E. Zcharia, A. Orgel, Z. Guatta-Rangini, T. Peretz, I. Vlodavsky, and H.K. Kleinman Regulation of heparanase gene expression by estrogen in breast cancer Cancer Res. 63 2003 8821 8826
17. D. Hanahan, and J. Folkman Patterns and Emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
18. I. Vlodavsky, and O. Goldshmidt Properties and function of heparanase in cancer metastasis and angiogenesis Haemostasis 31 2001 60 63
19. M. Nakajima, T. Irimura, and G.L. Nicholson Heparanase and tumor metastasis J. Cell Biochem. 36 1988 157 167
20. I. Vlodavsky, M. Mohsen, O. Lider, C.M. Svahn, H.P. Ekre, M. Vigoda, R. Ishai-Michaeli, and T. Peretz Inhibition of tumor metastasis by heparanase inhibiting species of heparin Invas. Metast. 14 1995 290 302
21. C.R. Parish, D.R. Coombe, K.B. Kakobsen, and P.A. Underwood Evidence that sulphated polysaccharides inhibit tumor metastasis by blocking tumor cell-derived heparanase Int. J. Cancer 40 1987 511 517
22. C.R. Parish, C. Freeman, K.J. Brown, D.J. Francis, and W.B. Cowden Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity Cancer Res. 59 1999 3433 3441
23. O. Lider, E. Baharav, Y.A. Mekori, T. Miller, Y. Naparstek, I. Vlodavsky, and I.R. Cohen Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins J. Clin. Invest. 83 1989 752 756
24. D.O. Willenborg, and C.R. Parish Inhibition of allergic encephalomyelitis in rats by treatment with sulfated polysaccharides J. Immunol. 140 1988 3401 3405
25. H. Prats, M. Kaghad, A.C. Prats, M. Klagsbrun, J.M. Lelias, P. Liauzun, P. Chalon, J.P. Tauber, F. Amalric, and J.A. Smith High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons Proc. Natl. Acad. Sci. USA 86 1989 1836 1840
26. M. Toyoshima, and M. Nakajima Human heparanase- purification, characterization, cloning, and expression J. Biol. Chem. 274 1999 24153 24160
27. C. Freeman, and C.R. Parish A rapid quantitative assay for the detection of mammalian heparanase activity Biochem. J. 325 1997 229 237
28. C. Freeman, and C.R. Parish Human platelet heparanase: purification, characterization and catalytic activity Biochem. J. 330 1998 1341 1350
29. I. Hemmila, S. Dakubu, V.M. Mukkala, H. Siitari, and T. Lovgren Europium as a label in time-resolved immunofluorometric assays Anal. Biochem. 137 1984 335 343
30. I. Hemmila, and S. Webb Time-resolved fluorometry: an overview of the labels and core technologies for drug screening applications Drug Discov. Today 2 1997 373 381
31. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other diseases Nat. Med. 1 1995 27 31
32. A. Satoh, E. Fukui, S. Yoshino, M. Shinoda, K. Kojima, and I. Matsumoto Comparison of methods of immobilization to enzyme-linked immunosorbent assay plates for the detection of sugar chains Anal. Biochem. 275 1999 231 235
33. F. Behzad, and P.E. Brenchley A multiwell format assay for heparanase Anal. Biochem. 320 2003 207 213
34. H. Ben-Artzi, M. Ayal-Hershkovitz, I. Vlodavsky, I. Pecker, Y. Peleg, D. Miron, Methods of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe, US Patent No: US 6 (2001) 190,875 B1
35. Z.-H. Zhang, T.Y. Chung, and K.R. Oldenburg A simple statistical parameter for use in evaluation and validation of high throughput screening assays J. Biomol. Screen. 4 1999 67 73